247 related articles for article (PubMed ID: 10584202)
1. Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis.
Moretti S; Alesse E; Marcellini S; Di Marzio L; Zazzeroni F; Parroni R; Famularo G; Boschini A; Cifone MG; De Simone C
Immunopharmacol Immunotoxicol; 1999 Nov; 21(4):645-65. PubMed ID: 10584202
[TBL] [Abstract][Full Text] [Related]
2. Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART.
Pandolfi F; Pierdominici M; Marziali M; Livia Bernardi M; Antonelli G; Galati V; D'Offizi G; Aiuti F
Clin Immunol; 2000 Mar; 94(3):153-9. PubMed ID: 10692234
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.
AIDS; 1999 Apr; 13(5):565-73. PubMed ID: 10203381
[TBL] [Abstract][Full Text] [Related]
6. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
[TBL] [Abstract][Full Text] [Related]
7. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
García F; Vidal C; Plana M; Cruceta A; Gallart MT; Pumarola T; Miro JM; Gatell JM
Clin Infect Dis; 2000 Feb; 30(2):392-4. PubMed ID: 10671348
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients.
Grelli S; d'Ettorre G; Lauria F; Montella F; Di Traglia L; Lichtner M; Vullo V; Favalli C; Vella S; Macchi B; Mastino A
J Antimicrob Chemother; 2004 Mar; 53(3):494-500. PubMed ID: 14963063
[TBL] [Abstract][Full Text] [Related]
9. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection.
Sloand EM; Maciejewski JP; Sato T; Bruny J; Kumar P; Kim S; Weichold FF; Young NS
J Clin Invest; 1998 Jan; 101(1):195-201. PubMed ID: 9421482
[TBL] [Abstract][Full Text] [Related]
12. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine.
Moretti S; Famularo G; Marcellini S; Boschini A; Santini G; Trinchieri V; Lucci L; Alesse E; De Simone C
Antioxid Redox Signal; 2002 Jun; 4(3):391-403. PubMed ID: 12215207
[TBL] [Abstract][Full Text] [Related]
13. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
[TBL] [Abstract][Full Text] [Related]
14. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.
Badley AD; Parato K; Cameron DW; Kravcik S; Phenix BN; Ashby D; Kumar A; Lynch DH; Tschopp J; Angel JB
Cell Death Differ; 1999 May; 6(5):420-32. PubMed ID: 10381636
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
[TBL] [Abstract][Full Text] [Related]
16. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
17. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
18. Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.
Malhotra U; Bosch RJ; Chan E; Wang R; Fischl MA; Collier AC; McElrath MJ
J Infect Dis; 2004 Feb; 189(3):515-9. PubMed ID: 14745710
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation.
Di Marzio L; Moretti S; D'Alò S; Zazzeroni F; Marcellini S; Smacchia C; Alesse E; Cifone MG; De Simone C
Clin Immunol; 1999 Jul; 92(1):103-10. PubMed ID: 10413658
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
